FACT Complex-targeting Curaxin CBL0137 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CBL0137

Filter by location:

Birmingham, Alabama1 trial

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Children's Hospital of Alabama

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.